Compare Abeona Therapeutics Inc (ABEO) vs Aterian Inc (ATER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Aterian Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Aterian Inc trades at $0.48 (market cap $5.32M). The key difference: Abeona Therapeutics Inc is far larger — about 79.2× Aterian Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Aterian Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | ATER | |
|---|---|---|
Market Cap | $421.19M | $5.32M |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $1.39 |
52-Week Low | $4.17 | $0.36 |
Enterprise Value | $276.10M | $5.90M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →
